摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3,5,6-tetrahydro-3,5-dioxo-2-phenethyl-1,2,6-thiadiazine 1,1-dioxide | 106350-03-2

中文名称
——
中文别名
——
英文名称
2,3,5,6-tetrahydro-3,5-dioxo-2-phenethyl-1,2,6-thiadiazine 1,1-dioxide
英文别名
1,1-Dioxo-2-(2-phenylethyl)-1,2,6-thiadiazinane-3,5-dione
2,3,5,6-tetrahydro-3,5-dioxo-2-phenethyl-1,2,6-thiadiazine 1,1-dioxide化学式
CAS
106350-03-2
化学式
C11H12N2O4S
mdl
——
分子量
268.293
InChiKey
UVIAYNFSGIDEAY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    91.9
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2,3,5,6-tetrahydro-3,5-dioxo-2-phenethyl-1,2,6-thiadiazine 1,1-dioxide盐酸溶剂黄146 、 sodium nitrite 作用下, 以 1,4-二氧六环 为溶剂, 反应 2.0h, 生成 4-amino-2-phenethyl-2,3-dihydro-3-oxo-1,2,5-thiadiazole 1,1-dioxide
    参考文献:
    名称:
    Aran, Vicente J.; Bielsa, Agustin G.; Ruiz, Jose R., Journal of the Chemical Society. Perkin transactions I, 1986, p. 643 - 646
    摘要:
    DOI:
  • 作为产物:
    描述:
    N-Phenethylsulfamide丙二酰氯甲苯 为溶剂, 以88%的产率得到2,3,5,6-tetrahydro-3,5-dioxo-2-phenethyl-1,2,6-thiadiazine 1,1-dioxide
    参考文献:
    名称:
    Aran, Vicente J.; Bielsa, Agustin G.; Ruiz, Jose R., Journal of the Chemical Society. Perkin transactions I, 1986, p. 643 - 646
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • ARAN, V. J.;BIELSA, A. G.;RUIZ, J. R.;STUD, M., J. CHEM. SOC. PERKIN TRANS., 1986, N 4, 643-645
    作者:ARAN, V. J.、BIELSA, A. G.、RUIZ, J. R.、STUD, M.
    DOI:——
    日期:——
  • [EN] THIADIAZINYL CORTICOTROPIN-RELEASING FACTOR BINDING PROTEIN LIGAND INHIBITORS<br/>[FR] INHIBITEURS DE LIGAND DE PROTEINE FIXATRICE DE FACTEUR DE LIBERATION DE CORTICOTROPHINE DE THIADIAZINYLE
    申请人:ELI LILLY AND COMPANY
    公开号:WO1998051312A1
    公开(公告)日:1998-11-19
    (EN) This invention provides novel derivatives of 2,3,5,6-tetrahydro-1,2,6-thiadiazin-3,5-dione 1,1-dioxide which are useful as ligand inhibitors for increasing levels of free corticotropin-releasing factor in the brain. Such ligand inhibitors cause release of corticotropin-releasing factor from the corticotropin-releasing factor/corticotropin-releasing factor binding protein complex. Administration of the ligand inhibitors provide improvement in learning and memory, and are useful in decreasing food intake.(FR) L'invention concerne de nouveaux dérivés de 2,3,5,6-tétrahydro-1,2,6-thiadiazine-3,5-dione 1,1-dioxyde, qui sont utiles comme inhibiteurs de ligand en vue d'accroître les taux de facteur de libération de corticotrophine libre dans le cerveau. Ces inhibiteurs de ligand provoquent la libération du facteur de libération de corticotrophine du complexe facteur de libération de corticotrophine/protéine fixatrice de facteur de libération de corticotrophine. L'administration des inhibiteurs de ligand permet d'améliorer les facultés d'apprentissage et la mémoire, et sont utiles pour permettre de réduire l'ingestion d'aliments.
  • Aran, Vicente J.; Bielsa, Agustin G.; Ruiz, Jose R., Journal of the Chemical Society. Perkin transactions I, 1986, p. 643 - 646
    作者:Aran, Vicente J.、Bielsa, Agustin G.、Ruiz, Jose R.、Stud, Manfred
    DOI:——
    日期:——
查看更多

同类化合物

牛磺胺 滔罗林 棉隆 四氢-5-(2-羟基乙基)-3-甲基-2H-1,3,5-噻二嗪-2-硫酮 四氢-3,5-二甲基-4,6-二苯基-2H-1,3,5-噻二嗪-2-硫酮 噻嗪酮 7-氧杂-2-硫杂-1,5-二氮杂双环[3.3.1]壬烷 4,6-二甲基-四氢-[1,3,5]噻二嗪-2-硫酮 3-异丙基-5-苯基-1,3,5-噻二嗪-2,4-二酮 3,5-二己基-1,3,5-噻二嗪烷-2-硫酮 3,4,5,6-四氢-4,6-二甲基-2-(3-吡啶基)-2H-1,3,4-噻二嗪 2-苯甲基-1,2,6-噻重氮基己环1,1-二氧化 2-甲基-[1,2,6]噻二烷 1,1-二氧化物 2,6-二甲基-4-(2-甲基丙基)-2H-1,2,6-噻二嗪-3,5(4H,6H)-二酮1,1-二氧化物 2,6-二丁基-4-(2-甲基丙基)-2H-1,2,6-噻二嗪-3,5(4H,6H)-二酮1,1-二氧化 1Λ6,2,6-噻二嗪烷-1,1-二酮 3-benzyl-5-(3-carboxypropyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione 7-oxa-2<λ>6-thia-1,5-diazabicyclo<3.3.1>nonane-2,2-dione 5-carboxyethyl-3-(2´-furfurylmethyl)-1,3,5-thiadiazinane-2-thione 5-carboxyethyl-3-cyclohexyl-1,3,5-thiadiazinane-2-thione tert-butyl 1,2,6-thiadiazinan-2-carboxylate 1,1-dioxide 3-Phenyl-3,4,5,6-tetrahydro-2H-<1,2,3>thiadiazin-1,1-dioxid 5-(2-hydroxyethyl)-3-n-propyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 3-i-butyl-5-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 2-[1-(4-pyridyl)ethyl]tetrahydro-1,2,6-thiadiazine-1,1-dioxide 2-Thio-3-phenaethyl-5-(2-hydroxy-aethyl)-tetrahydro-1,3,5-thiadiazin 3-cyclohexyl-5-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 5-(2-hydroxyethyl)-3-(1-phenylethyl)-1,3,5-thiadiazinane-2-thione 5-(2-hydroxyethyl)-3-n-pentyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 5-(2-hydroxyethyl)-3-i-propyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 3-ethyl-5-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 3-n-hexyl-5-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 3-Benzyl-5-[2-(diethylamino)ethyl]-1,3,5-thiadiazinane-2-thione;hydrochloride 4-[(5-Cyclohexyl-6-sulfanylidene-1,3,5-thiadiazinan-3-yl)methyl]cyclohexane-1-carboxylic acid 6-butyl-5-methyl-1,1-dioxo-1λ6-[1,2,6]thiadiazinan-3-one 2,4-dibutyl-[1,2,4]thiadiazinane 1,1-dioxide 2-[4-pyridylmethyl]tetrahydro-1,2,6-thiadiazine-1,1-dioxide 2-[2-(4-pyridyl)ethyl] tetrahydro-1,2,6-thiadiazine-1,1-dioxide 2-[2-(Pyridin-4-yl)propyl]-1lambda~6~,2,6-thiadiazinane-1,1-dione 3-Benzyl-5-methyl-1,3,5-thiadiazinane-2-thione 2,6-Dithia-1,3,7-triazaadamantane, 2,2,6,6-tetraoxide 3,5-Bis-<2-hydroxy-aethyl>-2-thioxo-tetrahydro-1,3,5-thiadiazin 5,6-Dihydro-5-methyl-2H-1,2,6-thiadiazin-3(4H)-one 1,1-dioxide 3-butyl-5-(2-hydroxyethyl)-1,3,5-thiadiazinane-2-thione 3-benzyl-5-(2-hydroxyethyl)-1,3,5-thiadiazinane-2-thione 3-Benzyl-5-cyclohexyl-[1,3,5]thiadiazinane-2-thione 2-tert-butyl-2,4,6-trimethylperhydro-1,3,4-thiadiazine Homopentamethylenetetramine 3,5-Diisopropyl-1,3,5-thiadiazinane-2-thione 2,2,4,6-Tetramethyl-[1,3,4]thiadiazinane